BLUE logo

Bluebird Bio (BLUE) Cash From Investing

Annual CFI

$154.95 M
-$95.50 M-38.13%

December 31, 2023


Summary


Performance

BLUE Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEcash flowmetrics:

Quarterly CFI

$466.00 K
-$1.16 M-71.25%

September 30, 2024


Summary


Performance

BLUE Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEcash flowmetrics:

TTM CFI

$5.22 M
-$61.62 M-92.19%

September 30, 2024


Summary


Performance

BLUE TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BLUE Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-38.1%+171.2%-92.8%
3 y3 years+283.7%-99.5%-97.9%
5 y5 years+122.8%-99.6%+102.7%

BLUE Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-72.5%at low-99.5%+171.2%-99.1%at low
5 y5-year-72.5%+283.7%-99.8%+100.1%-99.3%+102.7%
alltimeall time-72.5%+122.8%-99.8%+100.1%-99.3%+100.8%

Bluebird Bio Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$466.00 K(-71.3%)
$5.22 M(-92.2%)
Jun 2024
-
$1.62 M(-347.5%)
$66.83 M(-7.4%)
Mar 2024
-
-$655.00 K(-117.3%)
$72.16 M(-53.4%)
Dec 2023
$154.95 M(-38.1%)
$3.79 M(-93.9%)
$154.95 M(-39.1%)
Sep 2023
-
$62.08 M(+793.9%)
$254.41 M(+22.4%)
Jun 2023
-
$6.95 M(-91.5%)
$207.93 M(-20.8%)
Mar 2023
-
$82.14 M(-20.4%)
$262.66 M(+4.9%)
Dec 2022
$250.45 M(-55.5%)
$103.24 M(+561.4%)
$250.45 M(+20.3%)
Sep 2022
-
$15.61 M(-74.7%)
$208.14 M(-33.4%)
Jun 2022
-
$61.68 M(-11.8%)
$312.44 M(+0.4%)
Mar 2022
-
$69.93 M(+14.8%)
$311.13 M(-44.7%)
Dec 2021
$562.56 M(-767.0%)
$60.93 M(-49.2%)
$562.56 M(-13.5%)
Sep 2021
-
$119.91 M(+98.6%)
$650.44 M(-431.0%)
Jun 2021
-
$60.37 M(-81.2%)
-$196.48 M(-1680.8%)
Mar 2021
-
$321.35 M(+115.9%)
$12.43 M(-114.7%)
Dec 2020
-$84.34 M(-116.6%)
$148.82 M(-120.5%)
-$84.34 M(+69.0%)
Sep 2020
-
-$727.01 M(-370.0%)
-$49.91 M(-106.2%)
Jun 2020
-
$269.28 M(+19.9%)
$806.15 M(+4.8%)
Mar 2020
-
$224.58 M(+22.6%)
$769.30 M(+51.5%)
Dec 2019
$507.81 M(-174.7%)
$183.25 M(+42.0%)
$507.81 M(-626.0%)
Sep 2019
-
$129.04 M(-44.5%)
-$96.54 M(-49.6%)
Jun 2019
-
$232.43 M(-729.7%)
-$191.71 M(-57.6%)
Mar 2019
-
-$36.91 M(-91.2%)
-$451.62 M(-33.5%)
Dec 2018
-$679.43 M
-$421.09 M(-1343.3%)
-$679.43 M(+194.4%)
Sep 2018
-
$33.87 M(-223.2%)
-$230.75 M(-65.2%)
Jun 2018
-
-$27.49 M(-89.6%)
-$663.40 M(+15.0%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$264.73 M(-1059.4%)
-$576.90 M(+82.2%)
Dec 2017
-$316.63 M(-571.8%)
$27.59 M(-106.9%)
-$316.63 M(-33.6%)
Sep 2017
-
-$398.78 M(-775.7%)
-$476.78 M(+2482.6%)
Jun 2017
-
$59.02 M(-1425.0%)
-$18.46 M(+931.3%)
Mar 2017
-
-$4.45 M(-96.6%)
-$1.79 M(-102.7%)
Dec 2016
$67.11 M(-111.7%)
-$132.56 M(-322.7%)
$67.11 M(-412.0%)
Sep 2016
-
$59.53 M(-21.3%)
-$21.51 M(-90.7%)
Jun 2016
-
$75.69 M(+17.4%)
-$230.77 M(-26.6%)
Mar 2016
-
$64.45 M(-129.1%)
-$314.44 M(-45.0%)
Dec 2015
-$571.87 M(+263.8%)
-$221.17 M(+47.7%)
-$571.87 M(+77.0%)
Sep 2015
-
-$149.72 M(+1773.2%)
-$323.10 M(-7.4%)
Jun 2015
-
-$7.99 M(-95.9%)
-$348.95 M(+0.4%)
Mar 2015
-
-$192.98 M(-799.3%)
-$347.65 M(+121.2%)
Dec 2014
-$157.19 M(+1500.3%)
$27.59 M(-115.7%)
-$157.19 M(-17.3%)
Sep 2014
-
-$175.58 M(+2524.5%)
-$190.08 M(+1051.2%)
Jun 2014
-
-$6.69 M(+165.8%)
-$16.51 M(+43.2%)
Mar 2014
-
-$2.52 M(-52.4%)
-$11.53 M(+17.4%)
Dec 2013
-$9.82 M(-478.0%)
-$5.29 M(+162.5%)
-$9.82 M(+100.9%)
Sep 2013
-
-$2.02 M(+18.1%)
-$4.89 M(+67.7%)
Jun 2013
-
-$1.71 M(+110.1%)
-$2.92 M(+110.0%)
Mar 2013
-
-$812.00 K(+128.1%)
-$1.39 M(-153.4%)
Dec 2012
$2.60 M(-165.6%)
-$356.00 K(+768.3%)
$2.60 M(-12.0%)
Sep 2012
-
-$41.00 K(-77.1%)
$2.96 M(-1.4%)
Jun 2012
-
-$179.00 K(-105.6%)
$3.00 M(-5.6%)
Mar 2012
-
$3.17 M
$3.17 M
Dec 2011
-$3.96 M
-
-

FAQ

  • What is bluebird bio annual cash flow from investing activities?
  • What is the all time high annual CFI for bluebird bio?
  • What is bluebird bio annual CFI year-on-year change?
  • What is bluebird bio quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for bluebird bio?
  • What is bluebird bio quarterly CFI year-on-year change?
  • What is bluebird bio TTM cash flow from investing activities?
  • What is the all time high TTM CFI for bluebird bio?
  • What is bluebird bio TTM CFI year-on-year change?

What is bluebird bio annual cash flow from investing activities?

The current annual CFI of BLUE is $154.95 M

What is the all time high annual CFI for bluebird bio?

bluebird bio all-time high annual cash flow from investing activities is $562.56 M

What is bluebird bio annual CFI year-on-year change?

Over the past year, BLUE annual cash flow from investing activities has changed by -$95.50 M (-38.13%)

What is bluebird bio quarterly cash flow from investing activities?

The current quarterly CFI of BLUE is $466.00 K

What is the all time high quarterly CFI for bluebird bio?

bluebird bio all-time high quarterly cash flow from investing activities is $321.35 M

What is bluebird bio quarterly CFI year-on-year change?

Over the past year, BLUE quarterly cash flow from investing activities has changed by +$1.12 M (+171.15%)

What is bluebird bio TTM cash flow from investing activities?

The current TTM CFI of BLUE is $5.22 M

What is the all time high TTM CFI for bluebird bio?

bluebird bio all-time high TTM cash flow from investing activities is $806.15 M

What is bluebird bio TTM CFI year-on-year change?

Over the past year, BLUE TTM cash flow from investing activities has changed by -$66.94 M (-92.77%)